Ross Davidson
Ross Davidson, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
The use of the antimalarial chloroquine could provide the selective pressure for E.coli to develop fluoroquinolone resistance – that’s according to a study presented by Ross Davidson at ICAAC. He investigated this by looking at remote community from Guyana, who had access to chloroquine but not fluoroquinolones, and he began by telling Audio Medica about the link between the two.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.